CA1017325A - Halogenated phenylthioacetamidocephalosporin derivatives - Google Patents

Halogenated phenylthioacetamidocephalosporin derivatives

Info

Publication number
CA1017325A
CA1017325A CA159,574A CA159574A CA1017325A CA 1017325 A CA1017325 A CA 1017325A CA 159574 A CA159574 A CA 159574A CA 1017325 A CA1017325 A CA 1017325A
Authority
CA
Canada
Prior art keywords
phenylthioacetamidocephalosporin
halogenated
derivatives
phenylthioacetamidocephalosporin derivatives
halogenated phenylthioacetamidocephalosporin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA159,574A
Other languages
English (en)
Other versions
CA159574S (en
Inventor
George W. Huffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1017325A publication Critical patent/CA1017325A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/4009—Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
    • C08G18/4072—Mixtures of compounds of group C08G18/63 with other macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/0061—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof characterized by the use of several polymeric components
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2483/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon only; Derivatives of such polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Cephalosporin Compounds (AREA)
CA159,574A 1971-12-27 1972-12-20 Halogenated phenylthioacetamidocephalosporin derivatives Expired CA1017325A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21273971A 1971-12-27 1971-12-27
US28822772A 1972-09-11 1972-09-11

Publications (1)

Publication Number Publication Date
CA1017325A true CA1017325A (en) 1977-09-13

Family

ID=26907406

Family Applications (1)

Application Number Title Priority Date Filing Date
CA159,574A Expired CA1017325A (en) 1971-12-27 1972-12-20 Halogenated phenylthioacetamidocephalosporin derivatives

Country Status (17)

Country Link
JP (1) JPS4885593A (xx)
AR (1) AR201736A1 (xx)
AT (2) AT325202B (xx)
BE (1) BE793311A (xx)
CA (1) CA1017325A (xx)
CH (2) CH581662A5 (xx)
DE (1) DE2263439C2 (xx)
ES (2) ES410249A1 (xx)
FR (1) FR2166081A1 (xx)
GB (1) GB1405797A (xx)
HU (1) HU166211B (xx)
IE (1) IE37029B1 (xx)
IL (1) IL41162A (xx)
NL (1) NL7217698A (xx)
PH (1) PH9252A (xx)
SE (1) SE417208B (xx)
YU (1) YU37494B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329363B1 (en) 1997-12-12 2001-12-11 Eli Lilly And Company Cephalosporin antibiotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1321704A (fr) * 1962-04-03 1963-03-22 Lilly Co Eli Procédé pour préparer des dérivés 7-(mercapto-acylamido s-substitués) des céphalosporines c et nouveaux composés ainsi préparés
US3335136A (en) * 1965-12-27 1967-08-08 Lilly Co Eli Halophenylmercaptomethyl cephalosporins
JPS4849789A (xx) * 1971-10-25 1973-07-13

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329363B1 (en) 1997-12-12 2001-12-11 Eli Lilly And Company Cephalosporin antibiotics

Also Published As

Publication number Publication date
IL41162A0 (en) 1973-02-28
FR2166081A1 (en) 1973-08-10
DE2263439C2 (de) 1984-07-19
SE417208B (sv) 1981-03-02
DE2263439A1 (de) 1973-07-12
IE37029B1 (en) 1977-04-13
AT326269B (de) 1975-12-10
BE793311A (fr) 1973-06-27
ES438108A1 (es) 1977-05-16
PH9252A (en) 1975-07-30
YU37494B (en) 1984-08-31
ATA161374A (de) 1975-02-15
GB1405797A (en) 1975-09-10
CH581662A5 (xx) 1976-11-15
FR2166081B1 (xx) 1976-04-23
YU324572A (en) 1981-08-31
IE37029L (en) 1973-06-27
JPS4885593A (xx) 1973-11-13
NL7217698A (xx) 1973-06-29
ES410249A1 (es) 1976-04-01
CH555365A (fr) 1974-10-31
HU166211B (xx) 1975-02-28
AR201736A1 (es) 1975-04-15
AT325202B (de) 1975-10-10
IL41162A (en) 1975-08-31

Similar Documents

Publication Publication Date Title
CA969186A (en) Tetrahydroindanol derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
AU461957B2 (en) Lumilysergol derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU463679B2 (en) Dibenzocycloheptadioxolan derivatives
CA989401A (fr) Derives de la phenothiazine antispastiques
CA1017325A (en) Halogenated phenylthioacetamidocephalosporin derivatives
AU470552B2 (en) Aminocephalosporin derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
CA867769A (en) Fluoracylamino-trichloromethyl-methane derivatives
AU460553B2 (en) Halogenated pyridine derivatives
CA862754A (en) Benzothiazepin-4-one derivatives
AU463550B2 (en) Nitrofurylpyrimidine derivatives
CA869544A (en) Thieno-benzothiazine derivatives
CA863950A (en) Thienobenzothiazephine derivatives
CA862773A (en) N-phenylsuccinimide derivatives
CA888726A (en) 2-benzyhydryl-3-quinuclidinol derivatives
CA871716A (en) Norscopolamine derivatives
CA866804A (en) Spiro-azatetramethylene derivatives
AU479054B2 (en) Triazole-ethenyl-phenylene derivatives
AU475768B2 (en) Ergolene derivatives
AU475691B2 (en) 7-amino-indazole derivatives
CA871723A (en) Pyridyl-2-imidazolone derivatives
CA863356A (en) Indenopyridine derivatives